1.Barriers to breast cancer screening in Singapore: A literature review.
Priyanka RAJENDRAM ; Prachi SINGH ; Kok Teng HAN ; Vasuki UTRAVATHY ; Hwee Lin WEE ; Anand JHA ; Shyamala THILAGARATNAM ; Swathi PATHADKA
Annals of the Academy of Medicine, Singapore 2022;51(8):493-501
INTRODUCTION:
Breast cancer is a leading cause of cancer death among women, and its age-standardised incidence rate is one of the highest in Asia. We aimed to review studies on barriers to breast cancer screening to inform future policies in Singapore.
METHOD:
This was a literature review of both quantitative and qualitative studies published between 2012 and 2020 using PubMed, Google Scholar and Cochrane databases, which analysed the perceptions and behaviours of women towards breast cancer screening in Singapore.
RESULTS:
Through a thematic analysis based on the Health Belief Model, significant themes associated with low breast cancer screening uptake in Singapore were identified. The themes are: (1) high perceived barriers versus benefits, including fear of the breast cancer screening procedure and its possible outcomes, (2) personal challenges that impede screening attendance and paying for screening and treatment, and (3) low perceived susceptibility to breast cancer.
CONCLUSION
Perceived costs/barriers vs benefits of screening appear to be the most common barriers to breast cancer screening in Singapore. Based on the barriers identified, increasing convenience to get screened, reducing mammogram and treatment costs, and improving engagement with support groups are recommended to improve the screening uptake rate in Singapore.
Breast Neoplasms/epidemiology*
;
Early Detection of Cancer
;
Female
;
Health Knowledge, Attitudes, Practice
;
Humans
;
Mammography
;
Mass Screening
;
Singapore/epidemiology*
2.Nutrition support practices for critically ill patients with severe acute respiratory syndrome coronavirus-2: A multicentre observational study in Singapore.
Charles Chin Han LEW ; Puay Shi NG ; Kok Wah WONG ; Ser Hon PUAH ; Cassandra Duan Qi LIM ; Geetha KAYAMBU ; Andrew Yunkai LI ; Chee Hong TOH ; Jonathen VENKATACHALAM ; Amartya MUKHOPADHYAY
Annals of the Academy of Medicine, Singapore 2022;51(6):329-340
INTRODUCTION:
To improve the nutritional care and resource allocation of critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), we described their characteristics, treatment modalities and clinical outcomes, and compared their nutrition interventions against the American Society for Parenteral and Enteral Nutrition (ASPEN) recommendations.
METHODS:
This was a retrospective observational study conducted in 5 tertiary hospitals in Singapore. Characteristics, treatment modalities, clinical outcomes and nutrition interventions of critically ill patients with SARS-CoV-2 who received enteral and parenteral nutrition were collected between January and May 2020.
RESULTS:
Among the 83 critically ill patients with SARS-CoV-2, 22 (28%) were obese, 45 (54%) had hypertension, and 21 (25%) had diabetes. Neuromuscular blockade, prone therapy and dialysis were applied in 70% (58), 47% (39) and 35% (29) of the patients, respectively. Refeeding hypophosphataemia and hospital mortality occurred respectively in 6% (5) and 18% (15) of the critically ill patients with SARS-CoV-2. Late enteral nutrition and cardiovascular comorbidities were associated with higher hospital mortality (adjusted relative risk 9.00, 95% confidence interval [CI] 2.25-35.99; 6.30, 95% CI 1.15-34.40, respectively). Prone therapy was not associated with a higher incidence of high gastric residual volume (≥250mL). The minimum caloric (15kcal/kg) and protein (1.2g/kg) recommendations of ASPEN were achieved in 54% (39) and 0% of the patients, respectively.
CONCLUSION
The high obesity prevalence and frequent usage of neuromuscular blockade, prone therapy, and dialysis had considerable implications for the nutritional care of critically ill patients with SARS-CoV-2. They also did not receive adequate calories and protein. More audits should be conducted to refine nutritional interventions and guidelines for this ever-evolving disease.
COVID-19/therapy*
;
Critical Illness/therapy*
;
Humans
;
Nutritional Support
;
SARS-CoV-2
;
Singapore/epidemiology*
;
United States